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Abstract
Transthyretin (TTR), the major transporter of thyroid hor-
mones and vitamin A in cerebrospinal fluid (CSF), binds the
Alzheimer b-peptide and thus might confer protection against
neurodegeneration. In addition, altered TTR levels have been
described in the CSF of patients with psychiatric disorders, yet
its function in the CNS is far from understood. To determine
the role of TTR in behaviour we evaluated the performance of
TTR-null mice in standardized tasks described to assess
depression, exploratory activity and anxiety. We show that the
absence of TTR is associated with increased exploratory
activity and reduced signs of depressive-like behaviour. In
order to investigate the mechanism underlying these altera-
tions, we measured the levels of cathecolamines. We found
that the levels of noradrenaline were significantly increased in
the limbic forebrain of TTR-null mice. This report represents
the first clear indication that TTR plays a role in behaviour,
probably by modulation of the noradrenergic system.
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Transthyretin (TTR), a major protein synthesized by the
choroid plexus and the liver, is a plasma and cerebrospinal
ﬂuid (CSF) transporter of thyroxine (T4) and vitamin A
[retinol (through association with retinol-binding protein)
Kabat et al. 1942; Hagen and Elliott 1973]. Thyroid
hormones (THs) and vitamin A are essential for normal
brain development (Morriss-Kay and Ward 1999; Anderson
2001; Bernal 2002) and ﬂuctuations of their circulating levels
are reported to interfere with mood (Bauer et al. 2002).
Triiodothyronine and retinoic acid, the biologically active
compounds generated locally from T4 and retinol, respect-
ively, affect the expression of a wide range of genes upon
interacting with their nuclear receptors. Transcriptionally
active heterodimers of these two receptors have been
characterized indicating possible synergistic actions of both
molecules (Anderson 2001; Bernal 2002). Among the
processes regulated by THs and retinoids are differentiation
of the cerebellum, axonal migration and myelination, and
transcriptional regulation of enzymes, receptors and trans-
porters of the neurotransmitter cascades (Rodrigues-Pena
1999; Smith et al. 2001; Balmer and Blomhoff 2002).
Given its ontogenetic and phylogenetic expression pat-
terns, TTR was considered to be essential for delivering its
ligands to target tissues, particularly to the CNS (Southwell
et al. 1993; Schreiber et al. 1995). However, studies in TTR-
null mice have questioned whether TTR is indeed essential
for TH transfer into the brain (Palha et al. 2000, 2002; Palha
2002). TTR-null mice display signiﬁcantly reduced levels of
THs in the choroid plexus and no other protein appears to
replace TTR in the transport of T4 in the CSF (Palha et al.
2000). Furthermore, under normal physiological conditions,
distribution of THs within the brain is not impaired by the
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absence of TTR (Palha et al. 2002). In addition, TTR-null
mice do not present classical features of altered TH home-
ostasis (Episkopou et al. 1993; Palha et al. 1994, 1997).
Several reports suggest that TTR might have other
biologically relevant ligands (Palha 2002). Decreased levels
of TTR in the CSF have been observed in patients with
psychiatric disorders such as depression (Sullivan et al.
1999). Decreased TTR levels in the CSF have also been
found in patients with Alzheimer’s disease, although no
identiﬁed mutations of TTR are associated with the disease
(Riisoen 1988; Palha et al. 1996). TTR binds the Alzheimer
b-peptide (Schwarzman et al. 1994), possibly protecting
against neurodegeneration (Stein and Johnson 2002) and
mediating clearance of the brain b-peptide (Carro et al.
2002). TTR also binds pterins (cofactors in the biosynthesis
of cathecolamines; Ernstro¨m et al. 1995) and oxidation
products of norepinephrine (NE; Boomsma et al. 1991), and
therefore might inﬂuence cathecolaminergic function.
These observations underline the need to investigate
further the effect of TTR on behaviour, using established
behavioural paradigms. In order to assess its possible role in
regulating brain functions relevant to mental illness we
characterize, in the present study, the behaviour phenotype of
TTR-null mice. We show that TTR is involved in depression
and exploratory activity, probably as a consequence of
altered NE neurotransmission in the limbic forebrain.
Experimental procedures
Animals
Fifty TTR-null (25 female and 25 male) and 50 wild-type (25 female
and 25 male) mice of 129Sv/EV genetic background, bred
separately; and six TTR-null and six littermate wild-type were kept
and used strictly in accordance with National and European Union
guidelines for the care and handling of laboratory animals. Animals
in groups of ﬁve were housed in 26 · 20.5 · 14 cm cages,
separated by gender and genotype, weaned at 3 weeks of age and
given standard rodent chow and water ad libitum. Animals were
kept with a light/dark cycle of 12 h (light period from 08.00 to
20.00 h, 40 W), at 22.5C ± 1 and 55% ± 5 humidity.
All behavioural tests were carried out during the light phase of
the light/dark cycle. Between each test, animals were allowed to rest
for the same amount of time, for a period of at least 1 week. The
following experimental sequence of tests was performed in all
animals: forced swim test, elevated plus maze and open ﬁeld. A
separate group of animals was used for neurochemical analysis.
Animals were killed by careful and rapid decapitation; the brains
were removed, rapidly frozen and stored at )80C until analysis.
Eye opening and cage behaviour
Mice were qualitatively observed once a day from birth until
96 days of life and from then on once a week. The day of eye
opening was registered. Details of home cage locomotion, social
behaviour between males and maternal behaviour (nesting, nursing
and pup retrieval) were recorded.
Forced swim test
We used the forced swim test to evaluate the failure to seek escape
from an aversive stimulus. This test has been proposed to reﬂect
‘behavioural despair’, and shown to respond speciﬁcally to a wide
range of antidepressant drugs (Porsolt et al. 1978). Mice aged
10–12 weeks were placed in a 25 cm diameter, 10 cm water depth,
glass pool containing water at 25 ± 1C. During each trial the
mouse was left in the pool for 10 min. The animals were submitted
to two trials, each on two consecutive days. To score activity,
behaviours recorded on videotapes were rated in ﬁve categories:
immobility, slow swimming, fast swimming, struggling and total
turns in the pool; and analysed using the The Observer Basic 3.0
program (Noldus International Technology, Leesburg, VA, USA).
The frequency and duration of behavioural categories were scored
for both trials. The number of defecations was recorded.
Elevated plus maze
The elevated plus maze was used to measure anxiety-like behaviour.
In this test the mouse is presented with a conﬂict between its innate
tendency to explore novel spaces and its fear of open and/or elevated
places (File et al. 2000). Increased time spent in the open arms of
the maze is interpreted as a decrease in anxiety behaviour.
The elevated plus maze consisted of a plastic cross of two closed
arms (25 · 10 · 15 cm) and two open arm, (25 · 10 · 0 cm),
raised 50 cm above the ﬂoor. For each test, the subject was placed in
the centre of the cross, facing an open arm and was allowed to
explore the maze for 5 min. The session was videotaped. Using the
The Observer Basic 3.0 the numbers of entries into open arms,
closed arms and new arm; the percentage of time spent in open
arms, closed arms and arms intersection; and the head-dipping over
sides of open arms and the latency to enter in the ﬁrst arm were
measured. The number of defecations was recorded and the maze
was wiped with damp cloth with a neutral detergent.
Open field
The open ﬁeld test is commonly used to measure exploratory,
locomotor and anxiety-like behaviour (Bolivar et al. 2000). The
open ﬁeld used was a square arena (41 · 41 · 37 cm) with infrared
beams located 2 cm above the arena ﬂoor on both X and Y axes (to
monitor the central and peripheral horizontal activities) and 9 cm
above the ﬂoor on two sides of the chamber (to monitor vertical
activity; San Diego Instruments, San Diego, CA, USA). The mouse
was placed in the centre of the arena and allowed to explore the
arena for 12 min. Two trials each on two consecutive days were
performed. The number of defecations was recorded. Between
sessions, the arena was wiped as described above.
Neurochemistry
On the day of the analysis, brains were thawed and the following
regions dissected: cerebellum, brain stem, hippocampus, hypotha-
lamus, striatum, limbic forebrain (containing nucleus accumbens,
septal nuclei, prefrontal cortex, olfactory tuberculi and amygdala)
and cerebral cortex. All regions were homogenized in 20–40 vol of
cold 150 mmol/L potassium phosphate buffer, pH 6.8. An aliquot
was used for the analysis of protein concentration.
The contents of dopamine and NE were analysed using high-
performance liquid chromatography (HPLC) with electrochemical
detection according to our previously published method (Romero
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et al. 1995; Gonza´lez et al. 1999). For serotonin and 5-hidroxyin-
dolacetic acid, homogenates were diluted (½) in ice-cold 0.4 N
perchloric acid containing 0.4 mM sodium disulphite and 0.90 mM
EDTA. N-methyl-serotonin was added as an internal standard.
Supernatants of diluted homogenates were injected into the HPLC
system which consisted of a Spectra-Physics 8810 isocratic pump
and an RP-18 column (Spherisorb ODS-2; 125 mm, 4.6 mm, 5 lm
particle size; Waters, MA, USA). The mobile phase consisted of
100 mM citric acid, 100 mM sodium acetate, 1 mM EDTA and 7%
methanol (pH 4.2) and the ﬂow rate was 0.8 mL/min. The efﬂuent
was monitored with a Metrohm bioanalytical system amperometric
detector using a glassy carbon electrode. The potential was 0.80 V
relative to an Ag/AgCl reference electrode with a sensitivity of 50 nA
(approx. 2 ng/sample). The signal was recorded on a Spectra-Physics
4290 integrator. The results were given as area under the peaks and
calculated by comparison with the area under the corresponding
internal standard peak.
The activity of tyrosine hydroxylase was measured as previously
described (Nagatsu et al. 1979). The number of tyrosine hydroxylase
neurones was evaluated by immunohistochemistry with antityrosine
hydroxylase (Afﬁniti, Exeter, UK), on 40-lm brain sections,
counterstained with thionin using standard staining procedures.
The activity of monoamine oxidase A was measured in the
cerebellum and limbic forebrain homogenates (40 lg protein per
assay), using the Amplex Red Monoamine Oxidase Assay Kit
(Molecular Probes, Eugene, OR, USA).
Statistical analysis
The results were analysed using the statistical package Statistica 5.5
(StatSoft, Tulsa, OK, USA) and expressed as mean ± SEM.
Signiﬁcance was calculated using Student’s t-test, ANOVA or MANOVA.
Post-hoc Tukey test was performed when necessary. Differences
were considered signiﬁcant when p < 0.05.
Results
Eye opening and cage behaviour
Home cage behaviour did not differ between the two groups
of animals. Males did not display abnormal aggressive
behaviour and females presented typical maternal behav-
iours. Bilateral eye opening for both groups of animals
occurred, on average, at day 12.
Forced swim test
Using a three-way analysis of variance design – group (TTR-
null mice, wild-type) versus sex (male, female) versus trials
(trial 1, trial 2) – and as shown in Fig. 1, TTR-null mice were
signiﬁcantly more active than wild-type in both trials. TTR-
null mice exhibited less percentage of immobility time
(F1,95 ¼ 63.05, p < 0.0001), increased active behaviours
[slow swimming (F1,95 ¼ 55.32, p < 0.0001) and struggling
(F1,95 ¼ 28.02, p < 0.0001)] and made more turns in the
pool (F1,95 ¼ 37.28, p < 0.0001) than the control mice. No
statistically signiﬁcant gender differences within each
genotype were found.
A slight habituation was observed for both TTR-null and
wild-type mice from the ﬁrst to the second trial, as revealed
by the increase in immobility time (F1,95 ¼ 78.26,
p < 0.0001) and the total number of turns (F1,95 ¼ 26.73,
p < 0.001), and it was observed an interaction group versus
trials with a decrease in struggling time (F1,95 ¼ 46.83,
p < 0.0001). Only wild-type mice showed habituation for
slow swimming (F1,95 ¼ 10.65, p < 0.001).
When only the last 6 min of the ﬁrst trial were analysed
using non-paired Student’s t-test, the data were consistent
with the previous analysis.
Identical results were obtained when littermate TTR-null
and wild-type mice were used.
Elevated plus maze
Using a three-way analysis of variance design – group (TTR-
null mice, wild-type) versus sex (male, female) versus trials
(trial 1, trial 2, trial 3) – the results revealed that both the
TTR-null and the wild-type mice show a preference for the
closed versus the open arms of the maze (Fig. 2). For all
behavioural categories scored (time spent in the arms
intersection, closed arms, open arms; the number of entries
into closed arms and the number of head-dips), there were no
statistical signiﬁcant differences between the groups. No
statistically signiﬁcant gender differences within each geno-
type were found.
Open field activity
Using a three-way analysis of variance design – group (TTR-
null mice, wild-type) versus sex (male, female) versus trials
(trial 1, trial 2) – and as seen in Fig. 3, both male and female
TTR-null mice had statistically signiﬁcant increased loco-
motor activities when compared to wild-type mice.
Fig. 1 Forced swim test reveals increased activity of TTR-null mice.
Immobility (I), slow swimming (SS), fast swimming (FS) and struggling
(S) during first (1) and second (2) trials; *p < 0.0001.
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When horizontal activity was analysed, the TTR-null mice
were signiﬁcantly more active in central (F1,96 ¼ 30.49,
p < 0.0001) (Fig. 3b) and in peripheral activity
(F1,96 ¼ 26.73, p < 0.0001) (Fig. 3c). There was a signiﬁcant
interaction between genotype and sex. Tukey test analyses
indicated that, even though males were generally more active
than females in both groups, only for the wild-type a main
effect was observed (p < 0.006). From the ﬁrst to the second
trial, both groups displayed habituation, which was reﬂected
by a decrease in the central (F1,96 ¼ 32.74, p < 0.0001) and
peripheral (F1,96 ¼ 186.87, p < 0.0001) horizontal activities
in the second trial. Speciﬁcally, TTR-null mice perform
increased rearing relative to wild-type mice (F1,96 ¼ 79.05,
p < 0.0001) (Fig. 3a). An interaction between group versus
sex versus trials was observed (F1,96 ¼ 3.97, p < 0.049), but
only the TTR-null males showed a signiﬁcant decrease
between ﬁrst and second trials (p < 0.002).
TTR-null mice showed increased defecation compared to
wild-type mice (F1,96 ¼ 26.50, p < 0.0001). For both the
TTR-null and wild-type mice, an increased number of
defecations was observed from the ﬁrst to the second trials,
but no signiﬁcant interaction between genotype and trial was
found.
Identical results were obtained when littermate TTR-null
and wild-type mice were used.
Neurochemistry
TTR-null mice showed increased levels of NE in the limbic
forebrain while no differences were found in the other brain
regions examined (Fig. 4a). The data of the three different
groups of analyses were combined for presentation.
In addition, there were no statistically signiﬁcant differ-
ences between the two groups of animals for dopamine, even
though there is an evident trend of increased levels in the
TTR-null hippocampus (Fig. 4b) or for the activity of
tyrosine hydroxylase (data not shown).
Fig. 2 The elevated plus maze shows that both TTR-null and wild-
type mice were very anxious, spending most of the time in the closed




Fig. 3 TTR-null mice are more active than the wild-type, as assessed
by the open field vertical (a), horizontal central (b) and horizontal
peripheral activities (c); *p < 0.0001. Both genotypes revealed habi-
tuation from the first to the second trials in the central (F1,96 ¼ 32.74,
p < 0.0001) and peripheral (F1,96 ¼ 186.87, p < 0.0001) activities (#).
TTR, behaviour and the noradrenergic system 1055
 2004 International Society for Neurochemistry, J. Neurochem. (2004) 88, 1052–1058
The TTR-null mouse brain presented the same regional
distribution and number of tyrosine hydroxylase immuno-
positive neurones as the control mice, as determined by
immunohistochemistry (data not shown).
The level of serotonin (Fig. 4c) and of its major catabolic
metabolite, 5-hidroxyindolacetic acid (data not shown), were
not altered in the TTR-null mouse brain.
The mRNA level of monoamine oxidase A, determined by
RT–PCR (data not shown) was similar in both groups of
animals, as was the enzymatic activity of monoamine oxidase
A (Fig. 4d) as measured in tissue homogenates.
Discussion
Altered levels of TTR have been linked to a number of
neuronal dysfunctions. Reduced CSF TTR have been asso-
ciated with Alzheimer’s disease and depression in both
human and animal models (Riisoen 1988; Sullivan et al.
1999; Carro et al. 2002; Stein and Johnson 2002). Here we
show that TTR-null mice displayed decreased immobility in
the forced swimming test and increased exploratory activity
in the open ﬁeld test. Both alterations suggest an increased
behavioural response to stress, reﬂecting either decreased
behavioural inhibition or, alternatively, increased reactivity in
brain circuits mediating motor responses to stressful envi-
ronments. Yet, to the best of our knowledge, this is the ﬁrst
report demonstrating that TTR is implicated in behaviour.
It is well known that animals forced to swim in a restricted
space will rapidly cease apparent attempts to escape and
adopt a characteristic posture, termed ‘immobility’. Previous
experiments have consistently showed that immobility is
reduced by a variety of antidepressant agents and this test has
been extensively used as a screening model for antidepres-
sants (Porsolt et al. 1977). Thus, the present demonstration
that TTR-null mice are less prone to immobility in forced-
swimming might be viewed as a potential resistance to
depression. In support of this assumption, is the recent report
of decreased expression and synthesis of TTR in the choroid
plexus (Pulford et al. 2002) following chronic administration
of lithium chloride, a mood-stabilizing agent used in the
treatment of bipolar disorders. These consistent observations
apparently contradict the decreased levels of TTR found in
the CSF of a reduced sample of depressed individuals
(Sullivan et al. 1999). However, these might in fact be in
agreement if conﬁrmed, as discussed by Sullivan et al.
(2002) that the reduced levels of TTR could result from the
long-lasting effects of the psychotropic medication in course
prior to the analysis.
Performance in the open ﬁeld revealed that mice lacking
TTR showed increased motor activity and/or decreased
anxiety-like behaviours. It is more likely that the absence of
TTR inﬂuences locomotor activity since the use of a more
speciﬁc test for anxiety, the elevated plus maze, failed to
reveal increased signs of anxiety in wild-type mice.
The mechanism underlying the behaviour phenotype of
the TTR-null mice is probably related to the increased levels
of NE present in the limbic forebrain, as the concentrations of
serotonin and dopamine remain unaffected. In fact, drugs
increasing central dopaminergic and a-adrenergic activities
(Porsolt et al. 1979) reduce immobility in the forced
swimming test. In addition, the apparent discrepancy
observed between the open ﬁeld and elevated plus maze
tests (increased locomotor activity without associated hypo-
anxiety traits) probably reﬂects the speciﬁc activation of
distinct limbic regions. Indeed, while NE administration in
the nucleus accumbens or hippocampus is known to induce
increased locomotion in the open ﬁeld (with concomitant
reduced immobility in the forced-swimming test), NE
administration into the amygdala either reduces exploratory
activity or produces no effects in the elevated plus maze
(respectively if the release is in the basomedial or central
divisions; Plaznik et al. 1985a, 1985b).
In order to determine the mechanism by which the TTR-
null mice exhibit increased levels of NE in the limbic
(a) (b)
(c) (d)
Fig. 4 HPLC measurements in brain
regions revealed that TTR-null mice have
increased levels of norepinephrine (NE) in
the limbic forebrain (a) while no differences
are observed for dopamine (DA; b) and
serotonin (5-HT; c). The enzymatic activity
of monoamine oxidase A (MaoA) is normal
in the TTR-null mice (d). Five to 11 animals
were measured for each parameter. Lf,
limbic forebrain; Bstem, brain stem; Cb,
cerebellum; Cx, cortex; St, striatum;
Hpc, hippocampus; Hpt, hypothalamus;
*p < 0.005.
1056 J. C. Sousa et al.
 2004 International Society for Neurochemistry, J. Neurochem. (2004) 88, 1052–1058
forebrain, we have explored if such a difference resulted
from changes in NE metabolism. Neither tyrosine hydroxy-
lase activity, the rate-limiting enzyme in the cathecolamine
biosynthetic pathway, nor monoamine oxidase A, the major
NE catabolic enzyme, are affected in the TTR-null. Thus, the
increased levels of NE found in the limbic forebrain appear
to be the result of changes in NE not dependent on metabolic
activity. It is also possible that the TTR-null mice have an
altered limbic synaptic network; preliminary data showing a
reorganization of dendritic length and spines in the amygdala
of TTR-null mice strongly supportsthis hypothesis (Peˆgo
et al. 2003). Further studies will address whether manipula-
tion of the noradrenergic system with agonists and antago-
nists inﬂuence the observed phenotype.
The mechanism by which the absence of TTR relates to
the increased limbic levels of NE is still enigmatic.
Although TTR is the major carrier of thyroid hormones
in the CSF, TTR-null mice are euthyroid and therefore we
suggest that the role of TTR in behaviour is unlikely to
result from impaired hormonal homeostasis (Palha 2002;
Palha et al. 1994, 1997, 2000). However, the possibilities
of impaired occupancy of TH receptors or TH imbalance
earlier in development cannot be ruled out at this point.
Furthermore, we cannot exclude that the stressful exposure
to behaviour testing alters TH availability. In addition, it
must be remembered that TTR binds vitamin A, the
precursor of active 9-cis- and all-trans retinoid acid, which
interact with nuclear receptors (RXR and RAR) and
inﬂuence the expression of genes such as dopamine D2
receptor, dopamine b-hydroxylases and synapsins (Kim
et al. 2001; Balmer and Blomhoff 2002); yet, whether the
absence of TTR affects brain retinoid metabolism remains
to be elucidated.
Irrespective of the underlying mechanism, data presented
herein clearly reveal a role for TTR in behaviour. Such
involvement was shown to be associated with variations of
NE levels in the limbic system. The importance of this
ﬁnding deserves further investigation regarding both the
molecular mechanisms underlying this effect, as well as the
speciﬁc regions implicated in the process.
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